Delivery Order SPE2DB22D3102-SPE2DB24FL0WT

Award Date 4/18/24
Potential Completion Date 4/19/24
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The total potential value of this order is $3,210.65, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,156.26. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, with a completion date of February 15, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,849.24 contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML medical products and has a firm fixed-price pricing type. The contract has an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,987.54 to Amerisourcebergen Drug Corp's Corporate Office Division to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen supplies a comprehensive range of pharmaceutical products and medical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDIARIX 0.5 ML syringes. The contract has a ceiling value of $7,777.66 and an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide PEDIARIX 0.5ML syringes. The $15,902.20 delivery order has a completion date of February 6, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, including the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a potential value of $6,304.35 and a completion date of September 14, 2023. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order worth $5,571.20 for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $3,851.78 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML. This delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a completion date of February 6, 2024 and a potential value of $4,317.70. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not part of a larger contract vehicle. No set-aside designation was used for this award. Amerisourcebergen Drug...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL0WT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The $1,673.60 firm-fixed-price contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 7/18/24, 9:44 AM